Literature DB >> 18653553

Pain sensitivity and descending inhibition of pain in Parkinson's disease.

V Mylius1, I Engau, M Teepker, K Stiasny-Kolster, K Schepelmann, W H Oertel, S Lautenbacher, J C Möller.   

Abstract

BACKGROUND: Patients suffering from Parkinson's disease (PD) often complain about painful sensations. Recent studies detected increased subjective pain sensitivity and increased spinal nociception, which appeared to be reversible by dopaminergic treatment. Possibly, reduced descending pain inhibition contributes to this finding.
OBJECTIVE: Subjective pain thresholds as well as nociceptive reflex thresholds were investigated to isolate potential loci of the pathophysiological changes within the pain pathway. In addition, the diffuse noxious inhibitory control (DNIC) system as one form of descending control was assessed.
METHOD: 15 patients with PD and 18 controls participated in the study. Electrical and heat pain thresholds as well as the nociceptive flexion reflex (NFR) thresholds were determined. Thereafter, the electrical pain thresholds were measured once during painful heat stimulation (conditioning stimulation) and twice during innocuous stimulation (control stimulation).
RESULTS: Patients with PD exhibited lower electrical and heat pain thresholds as well as lower NFR thresholds. Suppression of the electrical pain thresholds during painful heat stimulation (conditioning stimulation) compared with control stimulation did not differ significantly between the groups. No differences in the thresholds between patients with PD with and without clinical pain were seen.
CONCLUSIONS: Finding the NFR threshold to be decreased in addition to the decreased electrical and heat pain thresholds indicates that the pathophysiological changes either already reside at or reach down to the spinal level. Reduced activation of the DNIC system was apparently not associated with increased pain sensitivity, suggesting that DNIC-like mechanisms do not significantly contribute to clinical pain in PD.

Entities:  

Mesh:

Year:  2008        PMID: 18653553     DOI: 10.1136/jnnp.2008.145995

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  36 in total

Review 1.  Conditioned pain modulation: a predictor for development and treatment of neuropathic pain.

Authors:  Yelena Granovsky
Journal:  Curr Pain Headache Rep       Date:  2013-09

Review 2.  Safety of Transcranial Magnetic Stimulation in Children: A Systematic Review of the Literature.

Authors:  Corey H Allen; Benzi M Kluger; Isabelle Buard
Journal:  Pediatr Neurol       Date:  2017-01-04       Impact factor: 3.372

Review 3.  Potential of animal models for advancing the understanding and treatment of pain in Parkinson's disease.

Authors:  Yazead Buhidma; Katarina Rukavina; Kallol Ray Chaudhuri; Susan Duty
Journal:  NPJ Parkinsons Dis       Date:  2020-01-06

4.  Transcranial Direct Current Stimulation Targeting Primary Motor Versus Dorsolateral Prefrontal Cortices: Proof-of-Concept Study Investigating Functional Connectivity of Thalamocortical Networks Specific to Sensory-Affective Information Processing.

Authors:  Vishwanath Sankarasubramanian; David A Cunningham; Kelsey A Potter-Baker; Erik B Beall; Sarah M Roelle; Nicole M Varnerin; Andre G Machado; Stephen E Jones; Mark J Lowe; Ela B Plow
Journal:  Brain Connect       Date:  2017-04

5.  Meta-analyses of seven GIGYF2 polymorphisms with Parkinson's disease.

Authors:  Dongjun Dai; Yunliang Wang; Xingyu Zhou; Jianmin Tao; Danjie Jiang; Hanlin Zhou; Yi Jiang; Guanghui Pan; Ping Ru; Huihui Ji; Jinfeng Li; Yuzheng Zhang; Honglei Yin; Mingqing Xu; Shiwei Duan
Journal:  Biomed Rep       Date:  2014-07-31

6.  The Neurotoxin DSP-4 Induces Hyperalgesia in Rats that is Accompanied by Spinal Oxidative Stress and Cytokine Production.

Authors:  Jillienne C Touchette; Joshua W Little; Gerald H Wilken; Daniela Salvemini; Heather Macarthur
Journal:  Neuroscience       Date:  2018-02-05       Impact factor: 3.590

Review 7.  Management of pain in Parkinson's disease.

Authors:  Munazza Sophie; Blair Ford
Journal:  CNS Drugs       Date:  2012-11       Impact factor: 5.749

Review 8.  Pathophysiology of somatosensory abnormalities in Parkinson disease.

Authors:  Antonella Conte; Nashaba Khan; Giovanni Defazio; John C Rothwell; Alfredo Berardelli
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

9.  Evaluation and management of the non-motor features of Parkinson's disease.

Authors:  Steven Wishart; Graeme J A Macphee
Journal:  Ther Adv Chronic Dis       Date:  2011-03       Impact factor: 5.091

10.  Dopaminergic denervation using [123I]-FPCIT and pain in Parkinson's disease: a correlation study.

Authors:  Estelle Dellapina; Jean Pellaprat; Djilali Adel; Jerome Llido; Estelle Harroch; Jean Baptiste Martini; Aurélie Kas; Anne Sophie Salabert; Fabienne Ory-Magne; Pierre Payoux; Christine Brefel-Courbon
Journal:  J Neural Transm (Vienna)       Date:  2019-01-31       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.